Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
about
The decreased growth hormone response to growth hormone releasing hormone in obesity is associated to cardiometabolic risk factors.Reduced amylin levels are associated with low bone mineral density in women with anorexia nervosaDeterminants of IGF1 and GH across the weight spectrum: from anorexia nervosa to obesityAssociation between serum growth hormone levels and nonalcoholic fatty liver disease: a cross-sectional study.Effects of a growth hormone-releasing hormone analog on endogenous GH pulsatility and insulin sensitivity in healthy men.Metabolic effects of a growth hormone-releasing factor in obese subjects with reduced growth hormone secretion: a randomized controlled trial.Determinants of bone mineral density in obese premenopausal womenEffects of growth hormone-releasing hormone on visceral fat, metabolic, and cardiovascular indices in human studies.Reduced growth hormone secretion in obesity is associated with smaller LDL and HDL particle sizeThe association of macro- and micronutrient intake with growth hormone secretionFNDC5 relates to skeletal muscle IGF-I and mitochondrial function and gene expression in obese men with reduced growth hormoneBody composition and skeletal health: too heavy? Too thin?Effects of GH in women with abdominal adiposity: a 6-month randomized, double-blind, placebo-controlled trialAndrogens may mediate a relative preservation of IGF-I levels in overweight and obese women despite reduced growth hormone secretion.The effects of central adiposity on growth hormone (GH) response to GH-releasing hormone-arginine stimulation testing in men.Anthropometry, CT, and DXA as predictors of GH deficiency in premenopausal women: ROC curve analysisEffects of GH on body composition and cardiovascular risk markers in young men with abdominal obesityBioactive insulin-like growth factor-I in obesity.Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls.Peak growth hormone-releasing hormone-arginine-stimulated growth hormone is inversely associated with intramyocellular and intrahepatic lipid content in premenopausal women with obesity.The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GHReduced growth hormone secretion is associated with increased carotid intima-media thickness in obesity.Effect of body mass index on peak growth hormone response to provocative testing in children with short stature.Discordance of IGF-1 and GH stimulation testing for altered GH secretion in obesity.The metabolic effects of growth hormone in adipose tissue.The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations.Bone mineral density in people living with HIV: a narrative review of the literature.Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.Dipeptidyl Peptidase-4 Inhibition Potentiates Stimulated Growth Hormone Secretion and Vasodilation in Women.Effects of recombinant human growth hormone administration on cardiovascular risk factors in obese children with relative growth hormone deficiency.Reduced peak stimulated growth hormone is associated with hyperuricemia in obese children and adolescents.
P2860
Q33633368-0FE079F4-D8EA-4214-ADE7-AC0FED4D329FQ33665366-A521FEA5-F7D8-4199-B436-AD5D5E749BF3Q34193008-BC53E2D2-1705-4723-AC76-612410B4F981Q34406289-DE154D77-EFB4-4C6E-9044-75608813B85BQ34571826-3AB24642-95E5-4D2B-BD61-C1BF99A03A43Q34643136-66F30AB6-6B5C-492A-B095-AFAB3327BD25Q34777653-25081DFF-2D80-409B-9B87-69E0169C3CBEQ35072510-E83BDD25-5325-42F2-826F-312E9E38A959Q35658885-448F5CDF-FDB5-4E12-B7A3-0F14F73A7896Q36083666-0E42E17F-BFB1-46C5-A843-A3D3E102E4C6Q36473167-82E13853-9195-4248-AE2B-47C676DF0ED4Q36642489-3D38DAF6-F220-4368-98A1-0C5826E3CC0AQ36837106-53852630-A07A-487D-9B00-8CD4C56A2BDBQ36964832-30412C74-B91F-4718-9E59-3CA829B4A84AQ36971944-629B41B1-8E0C-4FC9-A3AA-9669B70BB9D6Q37101164-09860C4E-97C3-4223-839E-275A33E4118FQ37149597-50BD83CD-7144-4637-8E59-9996A3FA6510Q37315693-2E9A22A2-A596-47C4-8BD6-65F0AAB7231CQ37315730-39CA9448-2CBE-4573-8647-B54307E4A085Q37379511-C8FFE296-97DF-43C6-88CE-299138FBE296Q37428975-40EADA6A-0AF7-4CED-A0A1-FE41588A0F37Q37482792-3E13DB1B-E1DD-476F-8BA4-82C2DC6C56E0Q37482808-F4769A9A-1B71-4FC6-BFD1-9391E1BD71E6Q37624695-BA106095-518A-42B6-911C-5B587CC3D850Q38083594-4F1CF7C8-8714-48A6-820F-75B8C047BFC4Q38097351-FB463382-99D1-45B4-BB67-422AA785C1B7Q40107245-1FEB52FA-3817-42B2-B8CC-82F97EB84339Q43268918-050D3B36-3168-4FDD-BF2E-6BA81596ED9FQ52686166-78FC5817-80A4-4D34-8F5B-962235032CAFQ53698784-EAAEE566-B239-425F-8B01-AC48ED9A0C88Q55088654-83B26CB1-7278-4F8F-BFF0-50335A37D44A
P2860
Growth hormone deficiency by growth hormone releasing hormone-arginine testing criteria predicts increased cardiovascular risk markers in normal young overweight and obese women.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Growth hormone deficiency by g ...... ng overweight and obese women.
@ast
Growth hormone deficiency by g ...... ng overweight and obese women.
@en
type
label
Growth hormone deficiency by g ...... ng overweight and obese women.
@ast
Growth hormone deficiency by g ...... ng overweight and obese women.
@en
prefLabel
Growth hormone deficiency by g ...... ng overweight and obese women.
@ast
Growth hormone deficiency by g ...... ng overweight and obese women.
@en
P2093
P2860
P356
P1476
Growth hormone deficiency by g ...... ng overweight and obese women.
@en
P2093
Ami Yamamoto
Andrea L Utz
Karen K Miller
Linda Hemphill
P2860
P304
P356
10.1210/JC.2008-0169
P407
P577
2008-04-29T00:00:00Z